Synip inhibitors, short for Synaptic Vesicle Protein Interaction inhibitors, represent a chemical class with a primary focus on modulating the intricate processes of synaptic transmission within the nervous system. Synaptic transmission is a fundamental mechanism that underlies communication between neurons and enables the transfer of information across neural circuits. Synip inhibitors, in particular, target the interactions between various synaptic vesicle proteins that are crucial for neurotransmitter release and regulation of synaptic plasticity.
At the molecular level, Synip inhibitors act by disrupting the binding or function of proteins involved in the exocytosis of neurotransmitter-containing vesicles at the synapse. These inhibitors are designed to interfere with the intricate protein-protein interactions that occur at the presynaptic terminal, where synaptic vesicles dock and fuse with the plasma membrane to release neurotransmitters into the synaptic cleft. By modulating these interactions, Synip inhibitors can regulate the timing and magnitude of neurotransmitter release, which in turn can influence the strength and plasticity of synaptic connections. Understanding and manipulating these interactions are essential for gaining insights into the fundamental mechanisms underlying neural communication and synaptic function, making Synip inhibitors a valuable tool for neuroscientists and researchers studying the intricacies of the nervous system.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits phosphoinositide 3-kinase (PI3K) by binding to its active site, preventing the phosphorylation of phosphatidylinositol lipids and downstream signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Blocks PI3K activity by binding to the ATP-binding site, preventing the formation of phosphatidylinositol 3,4,5-triphosphate (PIP3). | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR (mammalian target of rapamycin) signaling by forming a complex with FKBP12, which then binds to and inhibits mTORC1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK by binding to its ATP-binding site, blocking phosphorylation of downstream targets. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK1 and MEK2, preventing their activation and downstream ERK1/2 signaling. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
Selective GSK-3β inhibitor, interfering with its role in various signaling pathways, including Wnt and insulin signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK (c-Jun N-terminal kinase) by blocking its phosphorylation and activation, impacting stress response pathways. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $94.00 $413.00 | 16 | |
Selective inhibitor of EGFR (epidermal growth factor receptor) tyrosine kinase, disrupting downstream signaling cascades. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Inhibits NF-κB activation by preventing the degradation of IκBα, suppressing pro-inflammatory gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor that disrupts protein degradation, leading to accumulation of misfolded proteins and cell death. | ||||||